Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with clinical outcome (SORT OUT) X trial
Conclusion The SORT OUT X trial will determine whether the dual-therapy Combo stent is non-inferior to the Orsiro stent with respect to clinically driven events. (ClinicalTrials.gov NCT03216733).
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Angioplasty | Cardiology | Clinical Trials | Coronary Angioplasty | Denmark Health | Heart | Heart Attack | Netherlands Health | Percutaneous Coronary Intervention | PET Scan | Study | Switzerland Health